Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT01206647
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01206647
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Unknown status
Technical summary
Registry record NCT01206647. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Metformin and Saxagliptin
- Lead sponsor
- ikfe-CRO GmbH
- Collaborator
- AstraZeneca
- Collaborator
- IKFE Institute for Clinical Research and Development
Record details
- Record id
cardio:ct-nct01206647- Content hash
9681dba6c2ca75f761f2eb59bf4e7e585abeb87228768b0317328bcce1ff6cbd